The BMJ makes a long overdue demand: make the raw data from the vaccine trials available.
Pfizer’s pivotal covid vaccine trial was funded by the company and designed, run, analysed, and authored by Pfizer employees. The company and the contract research organisations that carried out the trial hold all the data. And Pfizer has indicated that it will not begin entertaining requests for trial data until May 2025, 24 months after the primary study completion date, which is listed on ClinicalTrials.gov as 15 May 2023 (NCT04368728).
The lack of access to data is consistent across vaccine manufacturers. Moderna says data “may be available … with publication of the final study results in 2022.” Datasets will be available “upon request and subject to review once the trial is complete,” which has an estimated primary completion date of 27 October 2022 (NCT04470427).
Note the end dates for the Pfizer and Moderna trials. Their vaccines are still being evaluated. This despite their being administered to hundreds of millions around the world.
People have a right to see all the data. That's what “informed consent” requires.
Show Us The Data
Show Us The Data
Show Us The Data
The BMJ makes a long overdue demand: make the raw data from the vaccine trials available.
Note the end dates for the Pfizer and Moderna trials. Their vaccines are still being evaluated. This despite their being administered to hundreds of millions around the world.
People have a right to see all the data. That's what “informed consent” requires.